Maxim has reduced its price target for AmpliTech Group from $9 to $7. The adjustment reflects ongoing market evaluations of the healthcare sector stock.
- AmpliTech Group price target lowered
- Maxim adjusts outlook
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.
Share this article